drugset / Trial / NCT04699240

Study of Lactobacillus in Adjuvant Treatment of RVVC

NCT04699240

Phase 4 Completed 140 enrolled Peking University Shenzhen Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

We are trying to determine if Clotrimazole vaginal tablets with oral Lactobacillus is better than Clotrimazole vaginal tablets in Preventing the Recurrence of vulvovaginalcandidiasis

Timeline

Start
2020-07-01
Primary completion
2023-12-30
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactobacillus Unknown 4 g Oral
Comparator Clotrimazole Unknown 500 mg Other